RxDoctor Payments Data

David Patalino, MD

Orthopaedic Surgery · New Hartford, NYNPI 1194782326

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (58.9%), education and speaking fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Prodigy Surgical Distribution, Inc. at 32.3% of the total. Reporting peaked in 2021 at $1,711 and has fallen 60.6% since, to $675 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in NY, where the typical reported total is $4,024.

$3,719in general payments, 2019–2025

Across 48 payments — averaging $77.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Prodigy Surgical Distribution, Inc.$1K
  • Johnson & Johnson$665
  • Lifenet Health$479
  • Smith+Nephew$327
  • Medacta USA, Inc.$278
  • Endo Pharmaceuticals Inc.$176
  • plus $593 from 12 others
$3,588in research payments, 2019–2025

Across 3 payments — averaging $1196.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$4K

What the payments were for

  • Speaking & faculty fees$3279%
  • Food & beverage$2,19259%
  • Education$1,20032%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,719 in reported general payments places this provider in the 45th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$102,093
Medicare patients
367
Services billed
2,448

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen187$1,223
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen61$890
Meloxicam271$663
Celecoxib28$457
Methylprednisolone43$314
Gabapentin11$114
Nabumetone14$92
Prednisone22$59
Tramadol Hcl23$52

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New Hartford

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →